S&D Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
S&D Co., Ltd. - overview
Established
1998
Location
Cheongju, Chungbuk, South Korea
Primary Industry
Food
About
Founded in 1998 and based in Cheongju, South Korea, S&D Co. , Ltd. operates as a manufacturer of health-oriented functional foods and food ingredients. In September 2021, S&D Co.
, Ltd. raised KRW 28. 64 billion in an IPO, selling 1. 02 million shares at KRW 28,000 per share below the expected price range of KRW 30,000 and KRW 32,000 on the KOSDAQ.
As part of the transaction, S&D Co. , Ltd. was partially delisted from the KOSDAQ market. As of 2023, the company trades on KOSDAQ under the ticker symbol 260970, and it is led by its CEO, Kyungmok Yeo.
S&D produces and sells various functional food and health-oriented materials, including Ecklonia extract, a sleep-induced health functional food; Rice bran ethanol extract; MPG-6/MPGT; RCS (rubus corneanus); Xanthorrhizol, which is an antibacterial material; Pagopyritol, which is a food material for lowering blood sugar and improving insulin resistance; SD 1002F, which is a dietary material; panduratin, which is an antibacterial material for various skin troubles and sensitive skin; and many more.
Current Investors
WOORI Venture Partners, Korea Venture Investment Corporation, Blue Corner
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements
Website
www.isnd.co.kr
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
S&D Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 12,175,046,282 | 12,683,074,886 | 15,403,841,452 | 21,704,983,232 | 36,418,114,847 | 37,538,609,954 | 46,304,509,665 | 56,537,326,854 | 61,401,611,130 | 73,317,425,404 | - | - | - |
| % Revenue Growth (YoY) | - | 4.2% | 21.5% | 40.9% | 67.8% | 3.1% | 23.4% | 22.1% | 8.6% | 19.4% | - | - | - |
| EBITDA (USD) | 394,542,134 | 1,080,985,090 | 1,502,183,284 | 2,234,814,047 | 4,739,675,765 | 5,618,394,635 | 7,868,984,474 | 10,665,624,921 | 10,679,642,271 | 12,508,729,743 | - | - | - |
| Operating Income (USD) | (1,382,841,649) | (723,021,956) | 267,209,031 | 1,210,747,959 | 3,778,695,112 | 4,252,386,441 | 6,335,858,110 | 9,124,215,921 | 9,178,461,271 | 10,945,850,743 | - | - | - |
| Operating Margin | (11.4%) | (5.7%) | 1.7% | 5.6% | 10.4% | 11.3% | 13.7% | 16.1% | 14.9% | 14.9% | - | - | - |
| % EBITDA Margin | 3.2% | 8.5% | 9.8% | 10.3% | 13.0% | 15.0% | 17.0% | 18.9% | 17.4% | 17.1% | - | - | - |
| NET Income (USD) | 3,221,415,723 | (462,869,011) | 268,026,106 | 1,290,077,049 | 3,305,143,651 | 3,317,286,407 | 4,863,517,980 | 7,358,956,640 | 7,693,436,526 | 9,846,024,417 | - | - | - |
| % Net Margin | 26.5% | (3.6%) | 1.7% | 5.9% | 9.1% | 8.8% | 10.5% | 13.0% | 12.5% | 13.4% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.